Related Experiment Videos
[Arm edema in cancer therapy: the number of examined lymph nodes a significant factor]
1Avdelningen för onkologi, Sahlgrenska Universitetssjukhuset, Göteborg.
Lakartidningen
|March 31, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.
British journal of cancer·2011
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
European journal of cancer (Oxford, England : 1990)·2006
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.
European journal of cancer (Oxford, England : 1990)·2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.
European journal of human genetics : EJHG·2002
A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer.
European journal of cancer (Oxford, England : 1990)·2001
[Rare manifestations of giant cell arteritis].
Lakartidningen·2026
[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].
Lakartidningen·2026
Catecholamine-Secreting Retroperitoneal Paraganglioma: A Case Report and Literature Review.
Case reports in urology·2026
Single-cell transcriptomics reveals transcriptional reprogramming and microenvironmental remodeling in ectopic ACTH/CRH-secreting pheochromocytomas.
Journal of translational medicine·2026
FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.
EMBO molecular medicine·2026